{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:12:43Z","timestamp":1788873163417,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CAMS Innovation Fund for Medical Science","award":["2019-I2M-5-044"],"award-info":[{"award-number":["2019-I2M-5-044"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872112"],"award-info":[{"award-number":["81872112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072857"],"award-info":[{"award-number":["82072857"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>CircRNAs are a novel class of evolutionarily conserved noncoding RNA molecules that form covalently closed continuous loop structures without 5\u2032 caps and 3\u2032 poly(A) tails. Accumulating evidence suggests that circRNAs play important regulatory roles in cancer and are promising biomarkers for cancer diagnosis and prognosis, as well as targets for cancer therapy. In this study, we identify and explore the role of a novel circRNA, circFBXO7, in ovarian cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>rRNA-depleted RNA-sequencing was performed to identify differentially expressed circRNAs between ovarian cancerous and normal tissues. qRT-PCR and single-molecule RNA in-situ hybridization was used to quantify circFBXO7 expression in tumor tissues. The association of circFBXO7 expression with patient prognosis was evaluated by Kaplan\u2013Meier survival analysis. The biological function of circFBXO7 was also investigated using loss-of-function and gain-of-function assays in vivo and in vitro. Luciferase reporter and TOP\/FOP-Flash reporter assays were then conducted together with RNA immunoprecipitation and western blot to assess the circFBXO7\/miR-96-5p\/MTSS1\/Wnt\/\u03b2-catenin axis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>circFBXO7 was downregulated in ovarian cancer which was associated with poor prognosis. Biologically, circFBXO7 overexpression significantly suppressed ovarian cancer cell proliferation, migration, and invasion in vitro, and inhibited tumor growth and metastasis in vivo, whereas its knockdown exerted an opposite role. Mechanistically, circFBXO7 functioned as a competing endogenous RNA for miR-96-5p to regulate the expression of MTSS1. Consequently, downregulation of MTSS1 led to excessive accumulation of \u03b2-catenin and increased phosphorylation of GSK3\u03b2, leading to the translocation of \u03b2-catenin to the nucleus, thereby activating the Wnt\/\u03b2-catenin signaling pathway and ultimately promoting ovarian cancer progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings indicate that circFBXO7 acts as a bone fide tumor suppressor in ovarian cancer and that the circFBXO7\/miR-96-5p\/MTSS1 axis is an important regulator in the Wnt\/\u03b2-catenin signaling pathway which may provide a promising target for ovarian cancer therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12943-022-01611-y","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T03:07:05Z","timestamp":1656472025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["circFBXO7\/miR-96-5p\/MTSS1 axis is an important regulator in the Wnt signaling pathway in ovarian cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Mengting","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongzi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juze","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoran","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"1611_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrm.2015.32","volume":"17","author":"LL Chen","year":"2016","unstructured":"Chen LL. The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 2016;17:205\u201311.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1611_CR2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1126\/science.1238522","volume":"340","author":"JE Wilusz","year":"2013","unstructured":"Wilusz JE, Sharp PA. Molecular biology. A circuitous route to noncoding RNA. Science. 2013;340:440\u20131.","journal-title":"Science"},{"key":"1611_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcancer.2018.12.002","volume":"58","author":"E Arnaiz","year":"2019","unstructured":"Arnaiz E, Sole C, Manterola L, Iparraguirre L, Otaegui D, Lawrie CH. CircRNAs and cancer: biomarkers and master regulators. Semin Cancer Biol. 2019;58:90\u20139.","journal-title":"Semin Cancer Biol"},{"key":"1611_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molcel.2014.08.019","volume":"56","author":"R Ashwal-Fluss","year":"2014","unstructured":"Ashwal-Fluss R, Meyer M, Pamudurti NR, Ivanov A, Bartok O, Hanan M, et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56:55\u201366.","journal-title":"Mol Cell"},{"key":"1611_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s13238-015-0202-0","volume":"6","author":"T Shen","year":"2015","unstructured":"Shen T, Han M, Wei G, Ni T. An intriguing RNA species--perspectives of circularized RNA. Protein Cell. 2015;6:871\u201380.","journal-title":"Protein Cell"},{"key":"1611_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17:272\u201383.","journal-title":"Nat Rev Genet"},{"key":"1611_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"WY Zhou","year":"2020","unstructured":"Zhou WY, Cai ZR, Liu J, Wang DS, Ju HQ, Xu RH. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19:172.","journal-title":"Mol Cancer"},{"issue":"9\u201321","key":"1611_CR8","volume":"66","author":"NR Pamudurti","year":"2017","unstructured":"Pamudurti NR, Bartok O, Jens M, Ashwal-Fluss R, Stottmeister C, Ruhe L, et al. Translation of CircRNAs. Mol Cell. 2017;66(9\u201321):e27.","journal-title":"Mol Cell"},{"key":"1611_CR9","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/hep.30671","volume":"70","author":"Q Li","year":"2019","unstructured":"Li Q, Pan X, Zhu D, Deng Z, Jiang R, Wang X. Circular RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma through the miR-338-3p\/PKM2 Axis under hypoxic stress. Hepatology. 2019;70:1298\u2013316.","journal-title":"Hepatology"},{"key":"1611_CR10","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1038\/s41467-019-11162-4","volume":"10","author":"Z Cheng","year":"2019","unstructured":"Cheng Z, Yu C, Cui S, Wang H, Jin H, Wang C, et al. circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. Nat Commun. 2019;10:3200.","journal-title":"Nat Commun"},{"key":"1611_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12943-019-1094-z","volume":"18","author":"F Yang","year":"2019","unstructured":"Yang F, Hu A, Li D, Wang J, Guo Y, Liu Y, et al. Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation. Mol Cancer. 2019;18:158.","journal-title":"Mol Cancer"},{"issue":"22\u201337","key":"1611_CR12","volume":"66","author":"I Legnini","year":"2017","unstructured":"Legnini I, Di Timoteo G, Rossi F, Morlando M, Briganti F, Sthandier O, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in Myogenesis. Mol Cell. 2017;66(22\u201337):e29.","journal-title":"Mol Cell"},{"key":"1611_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13059-020-02250-6","volume":"22","author":"X Wu","year":"2021","unstructured":"Wu X, Xiao S, Zhang M, Yang L, Zhong J, Li B, et al. A novel protein encoded by circular SMO RNA is essential for hedgehog signaling activation and glioblastoma tumorigenicity. Genome Biol. 2021;22:33.","journal-title":"Genome Biol"},{"key":"1611_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-017-0663-2","volume":"16","author":"S Meng","year":"2017","unstructured":"Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16:94.","journal-title":"Mol Cancer"},{"issue":"869\u2013881","key":"1611_CR15","volume":"176","author":"JN Vo","year":"2019","unstructured":"Vo JN, Cieslik M, Zhang Y, Shukla S, Xiao L, Zhang Y, et al. The landscape of circular RNA in Cancer. Cell. 2019;176(869\u2013881):e813.","journal-title":"Cell"},{"key":"1611_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"1611_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2644","volume":"9","author":"RC Bast Jr","year":"2009","unstructured":"Bast RC Jr, Hennessy B, Mills GB. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer. 2009;9:415\u201328.","journal-title":"Nat Rev Cancer"},{"issue":"607\u2013617","key":"1611_CR18","first-page":"601SI-604SI","volume":"183","author":"A Bounoutas","year":"2009","unstructured":"Bounoutas A, Zheng Q, Nonet ML, Chalfie M. Mec-15 encodes an F-box protein required for touch receptor neuron mechanosensation, synapse formation and development. Genetics. 2009;183(607\u2013617):601SI-604SI.","journal-title":"Genetics"},{"key":"1611_CR19","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1038\/sj.emboj.7600775","volume":"24","author":"H Laman","year":"2005","unstructured":"Laman H, Funes JM, Ye H, Henderson S, Galinanes-Garcia L, Hara E, et al. Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D\/cdk6. EMBO J. 2005;24:3104\u201316.","journal-title":"EMBO J"},{"key":"1611_CR20","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1073\/pnas.0736949100","volume":"100","author":"WY Kim","year":"2003","unstructured":"Kim WY, Geng R, Somers DE. Circadian phase-specific degradation of the F-box protein ZTL is mediated by the proteasome. Proc Natl Acad Sci U S A. 2003;100:4933\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1611_CR21","doi-asserted-by":"publisher","first-page":"192 e191","DOI":"10.1016\/j.neurobiolaging.2016.01.003","volume":"40","author":"S Conedera","year":"2016","unstructured":"Conedera S, Apaydin H, Li Y, Yoshino H, Ikeda A, Matsushima T, et al. FBXO7 mutations in Parkinson's disease and multiple system atrophy. Neurobiol Aging. 2016;40:192 e191\u20135.","journal-title":"Neurobiol Aging"},{"key":"1611_CR22","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 2013;14:R36.","journal-title":"Genome Biol"},{"key":"1611_CR23","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1101\/gr.202895.115","volume":"26","author":"XO Zhang","year":"2016","unstructured":"Zhang XO, Dong R, Zhang Y, Zhang JL, Luo Z, Zhang J, et al. Diverse alternative back-splicing and alternative splicing landscape of circular RNAs. Genome Res. 2016;26:1277\u201387.","journal-title":"Genome Res"},{"key":"1611_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-019-1080-5","volume":"18","author":"L Zhang","year":"2019","unstructured":"Zhang L, Zhou Q, Qiu Q, Hou L, Wu M, Li J, et al. CircPLEKHM3 acts as a tumor suppressor through regulation of the miR-9\/BRCA1\/DNAJB6\/KLF4\/AKT1 axis in ovarian cancer. Mol Cancer. 2019;18:144.","journal-title":"Mol Cancer"},{"key":"1611_CR25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13059-019-1910-1","volume":"20","author":"S Kovaka","year":"2019","unstructured":"Kovaka S, Zimin AV, Pertea GM, Razaghi R, Salzberg SL, Pertea M. Transcriptome assembly from long-read RNA-seq alignments with StringTie2. Genome Biol. 2019;20:278.","journal-title":"Genome Biol"},{"key":"1611_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nbt.2450","volume":"31","author":"C Trapnell","year":"2013","unstructured":"Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol. 2013;31:46\u201353.","journal-title":"Nat Biotechnol"},{"key":"1611_CR27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer genome atlas research N","year":"2011","unstructured":"Cancer genome atlas research N. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609\u201315.","journal-title":"Nature"},{"key":"1611_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13048-019-0533-1","volume":"12","author":"B Liu","year":"2019","unstructured":"Liu B, Zhang J, Yang D. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1. J Ovarian Res. 2019;12:57.","journal-title":"J Ovarian Res"},{"key":"1611_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2019.05.032","volume":"44","author":"S Wei","year":"2019","unstructured":"Wei S, Zheng Y, Jiang Y, Li X, Geng J, Shen Y, et al. The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p. EBioMedicine. 2019;44:182\u201393.","journal-title":"EBioMedicine"},{"key":"1611_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13046-019-1119-x","volume":"38","author":"M Vahabi","year":"2019","unstructured":"Vahabi M, Pulito C, Sacconi A, Donzelli S, D'Andrea M, Manciocco V, et al. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells. J Exp Clin Cancer Res. 2019;38:141.","journal-title":"J Exp Clin Cancer Res"},{"key":"1611_CR31","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1373\/clinchem.2015.238691","volume":"61","author":"N Matamala","year":"2015","unstructured":"Matamala N, Vargas MT, Gonzalez-Campora R, Minambres R, Arias JI, Menendez P, et al. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection. Clin Chem. 2015;61:1098\u2013106.","journal-title":"Clin Chem"},{"key":"1611_CR32","doi-asserted-by":"crossref","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.","DOI":"10.7554\/eLife.05005"},{"key":"1611_CR33","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48:D127\u201331.","journal-title":"Nucleic Acids Res"},{"key":"1611_CR34","first-page":"D148","volume":"48","author":"HY Huang","year":"2020","unstructured":"Huang HY, Lin YC, Li J, Huang KY, Shrestha S, Hong HC, et al. miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database. Nucleic Acids Res. 2020;48:D148\u201354.","journal-title":"Nucleic Acids Res"},{"key":"1611_CR35","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.ejca.2009.02.019","volume":"45","author":"C Parr","year":"2009","unstructured":"Parr C, Jiang WG. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. Eur J Cancer. 2009;45:1673\u201383.","journal-title":"Eur J Cancer"},{"key":"1611_CR36","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/leu.2015.329","volume":"30","author":"M Schemionek","year":"2016","unstructured":"Schemionek M, Herrmann O, Reher MM, Chatain N, Schubert C, Costa IG, et al. Mtss1 is a critical epigenetically regulated tumor suppressor in CML. Leukemia. 2016;30:823\u201332.","journal-title":"Leukemia"},{"key":"1611_CR37","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.humpath.2007.01.004","volume":"38","author":"S Ma","year":"2007","unstructured":"Ma S, Guan XY, Lee TK, Chan KW. Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma. Hum Pathol. 2007;38:1201\u20136.","journal-title":"Hum Pathol"},{"key":"1611_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13046-016-0361-8","volume":"35","author":"XY Huang","year":"2016","unstructured":"Huang XY, Huang ZL, Xu B, Chen Z, Re TJ, Zheng Q, et al. Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma. J Exp Clin Cancer Res. 2016;35:85.","journal-title":"J Exp Clin Cancer Res"},{"key":"1611_CR39","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1038\/ncomms4465","volume":"5","author":"KD Mertz","year":"2014","unstructured":"Mertz KD, Pathria G, Wagner C, Saarikangas J, Sboner A, Romanov J, et al. MTSS1 is a metastasis driver in a subset of human melanomas. Nat Commun. 2014;5:3465.","journal-title":"Nat Commun"},{"key":"1611_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc3419","volume":"13","author":"JN Anastas","year":"2013","unstructured":"Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13:11\u201326.","journal-title":"Nat Rev Cancer"},{"key":"1611_CR41","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169:985\u201399.","journal-title":"Cell"},{"key":"1611_CR42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrc2389","volume":"8","author":"A Klaus","year":"2008","unstructured":"Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8:387\u201398.","journal-title":"Nat Rev Cancer"},{"key":"1611_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1006\/dbio.1997.8552","volume":"185","author":"CM Hedgepeth","year":"1997","unstructured":"Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol. 1997;185:82\u201391.","journal-title":"Dev Biol"},{"key":"1611_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.67","volume":"4","author":"NI Herath","year":"2014","unstructured":"Herath NI, Rocques N, Garancher A, Eychene A, Pouponnot C. GSK3-mediated MAF phosphorylation in multiple myeloma as a potential therapeutic target. Blood Cancer J. 2014;4:e175.","journal-title":"Blood Cancer J"},{"key":"1611_CR45","first-page":"8","volume":"2017","author":"AM Baker","year":"1998","unstructured":"Baker AM, Huang W, Wang XM, Jansen M, Ma XJ, Kim J, et al. Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution. Nat Commun. 1998;2017:8.","journal-title":"Nat Commun"},{"key":"1611_CR46","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1158\/1078-0432.CCR-19-4088","volume":"26","author":"AT Sengal","year":"2020","unstructured":"Sengal AT, Patch AM, Snell CE, Smith DS, Leung SCY, Talhouk A, et al. FGFR2c Mesenchymal isoform expression is associated with poor prognosis and further refines risk stratification within endometrial Cancer molecular subtypes. Clin Cancer Res. 2020;26:4569\u201380.","journal-title":"Clin Cancer Res"},{"key":"1611_CR47","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li Z, Huang C, Bao C, Chen L, Lin M, Wang X, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22:256\u201364.","journal-title":"Nat Struct Mol Biol"},{"key":"1611_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1478","volume":"9","author":"JE Wilusz","year":"2018","unstructured":"Wilusz JE. A 360 degrees view of circular RNAs: from biogenesis to functions. Wiley Interdiscip Rev RNA. 2018;9:e1478.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"1611_CR49","first-page":"2757","volume":"19","author":"X Yin","year":"2020","unstructured":"Yin X, Chai Z, Sun X, Chen J, Wu X, Yang L, et al. Overexpression of microRNA-96 is associated with poor prognosis and promotes proliferation, migration and invasion in cholangiocarcinoma cells via MTSS1. Exp Ther Med. 2020;19:2757\u201365.","journal-title":"Exp Ther Med"},{"key":"1611_CR50","first-page":"3464","volume":"15","author":"W Xie","year":"2018","unstructured":"Xie W, Sun F, Chen L, Cao X. miR-96 promotes breast cancer metastasis by suppressing MTSS1. Oncol Lett. 2018;15:3464\u201371.","journal-title":"Oncol Lett"},{"key":"1611_CR51","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3892\/ijo.2015.3121","volume":"47","author":"R Liu","year":"2015","unstructured":"Liu R, Martin TA, Jordan NJ, Ruge F, Ye L, Jiang WG. Metastasis suppressor 1 expression in human ovarian cancer: the impact on cellular migration and metastasis. Int J Oncol. 2015;47:1429\u201339.","journal-title":"Int J Oncol"},{"key":"1611_CR52","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1083\/jcb.200609176","volume":"176","author":"PK Mattila","year":"2007","unstructured":"Mattila PK, Pykalainen A, Saarikangas J, Paavilainen VO, Vihinen H, Jokitalo E, et al. Missing-in-metastasis and IRSp53 deform PI(4,5)P2-rich membranes by an inverse BAR domain-like mechanism. J Cell Biol. 2007;176:953\u201364.","journal-title":"J Cell Biol"},{"issue":"95\u2013106","key":"1611_CR53","volume":"24","author":"K Kawabata Galbraith","year":"2018","unstructured":"Kawabata Galbraith K, Fujishima K, Mizuno H, Lee SJ, Uemura T, Sakimura K, et al. MTSS1 regulation of actin-nucleating Formin DAAM1 in dendritic Filopodia determines final dendritic configuration of Purkinje cells. Cell Rep. 2018;24(95\u2013106):e109.","journal-title":"Cell Rep"},{"key":"1611_CR54","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1242\/jcs.02640","volume":"118","author":"G Bompard","year":"2005","unstructured":"Bompard G, Sharp SJ, Freiss G, Machesky LM. Involvement of Rac in actin cytoskeleton rearrangements induced by MIM-B. J Cell Sci. 2005;118:5393\u2013403.","journal-title":"J Cell Sci"},{"key":"1611_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.str.2006.12.005","volume":"15","author":"SH Lee","year":"2007","unstructured":"Lee SH, Kerff F, Chereau D, Ferron F, Klug A, Dominguez R. Structural basis for the actin-binding function of missing-in-metastasis. Structure. 2007;15:145\u201355.","journal-title":"Structure"},{"key":"1611_CR56","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.devcel.2010.07.009","volume":"19","author":"M Bershteyn","year":"2010","unstructured":"Bershteyn M, Atwood SX, Woo WM, Li M, Oro AE. MIM and cortactin antagonism regulates ciliogenesis and hedgehog signaling. Dev Cell. 2010;19:270\u201383.","journal-title":"Dev Cell"},{"key":"1611_CR57","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cell.2012.05.002","volume":"149","author":"VS Li","year":"2012","unstructured":"Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP, et al. Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex. Cell. 2012;149:1245\u201356.","journal-title":"Cell"},{"key":"1611_CR58","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.tibs.2018.06.003","volume":"43","author":"C Cui","year":"2018","unstructured":"Cui C, Zhou X, Zhang W, Qu Y, Ke X. Is beta-catenin a Druggable target for Cancer therapy? Trends Biochem Sci. 2018;43:623\u201334.","journal-title":"Trends Biochem Sci"},{"key":"1611_CR59","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1136\/gutjnl-2014-307191","volume":"64","author":"M Soutto","year":"2015","unstructured":"Soutto M, Peng D, Katsha A, Chen Z, Piazuelo MB, Washington MK, et al. Activation of beta-catenin signalling by TFF1 loss promotes cell proliferation and gastric tumorigenesis. Gut. 2015;64:1028\u201339.","journal-title":"Gut"},{"key":"1611_CR60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00018-022-04147-y","volume":"79","author":"M Chen","year":"2022","unstructured":"Chen M, Shan L, Gan Y, Tian L, Zhou J, Zhu E, et al. Metastasis suppressor 1 controls osteoblast differentiation and bone homeostasis through regulating Src-Wnt\/beta-catenin signaling. Cell Mol Life Sci. 2022;79:107.","journal-title":"Cell Mol Life Sci"},{"key":"1611_CR61","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1083\/jcb.200910136","volume":"189","author":"GA Quinones","year":"2010","unstructured":"Quinones GA, Jin J, Oro AE. I-BAR protein antagonism of endocytosis mediates directional sensing during guided cell migration. J Cell Biol. 2010;189:353\u201367.","journal-title":"J Cell Biol"},{"key":"1611_CR62","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.bbrc.2003.12.021","volume":"313","author":"K Haraguchi","year":"2004","unstructured":"Haraguchi K, Nishida A, Ishidate T, Akiyama T. Activation of beta-catenin-TCF-mediated transcription by non-receptor tyrosine kinase v-Src. Biochem Biophys Res Commun. 2004;313:841\u20134.","journal-title":"Biochem Biophys Res Commun"},{"key":"1611_CR63","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1128\/MCB.25.12.5031-5039.2005","volume":"25","author":"R Karni","year":"2005","unstructured":"Karni R, Gus Y, Dor Y, Meyuhas O, Levitzki A. Active Src elevates the expression of beta-catenin by enhancement of cap-dependent translation. Mol Cell Biol. 2005;25:5031\u20139.","journal-title":"Mol Cell Biol"},{"key":"1611_CR64","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1242\/jcs.051847","volume":"122","author":"N Yokoyama","year":"2009","unstructured":"Yokoyama N, Malbon CC. Dishevelled-2 docks and activates Src in a Wnt-dependent manner. J Cell Sci. 2009;122:4439\u201351.","journal-title":"J Cell Sci"},{"key":"1611_CR65","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1096\/fj.12-222620","volume":"27","author":"S Condello","year":"2013","unstructured":"Condello S, Cao L, Matei D. Tissue transglutaminase regulates beta-catenin signaling through a c-Src-dependent mechanism. FASEB J. 2013;27:3100\u201312.","journal-title":"FASEB J"},{"key":"1611_CR66","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.15252\/embr.201439644","volume":"15","author":"Q Chen","year":"2014","unstructured":"Chen Q, Su Y, Wesslowski J, Hagemann AI, Ramialison M, Wittbrodt J, et al. Tyrosine phosphorylation of LRP6 by Src and Fer inhibits Wnt\/beta-catenin signalling. EMBO Rep. 2014;15:1254\u201367.","journal-title":"EMBO Rep"},{"key":"1611_CR67","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.tibs.2009.10.002","volume":"35","author":"D Wu","year":"2010","unstructured":"Wu D, Pan W. GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem Sci. 2010;35:161\u20138.","journal-title":"Trends Biochem Sci"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-022-01611-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-022-01611-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-022-01611-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T04:08:22Z","timestamp":1656475702000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-022-01611-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1611"],"URL":"https:\/\/doi.org\/10.1186\/s12943-022-01611-y","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"18 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethnics Committees of Women\u2019s Hospital of Zhejiang University School of Medicine (Hangzhou, China). The study was conducted in accordance with the International Ethical Guidelines for Biomedical Research Involving Human Subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}